Based on recent data, Core Laboratories N.V. (CLB) shows an Average True Range (ATR) of 0.65 and an Enterprise Value of 974.93M. Its average trading volume over the past 3 months is 512.38K, indicating liquidity. These fundamental metrics provide insight into CLB's underlying financial health and market activity.
Core Laboratories N.V. (CLB) technical indicators as of December 23, 2025: the SMA 20 is 2.99%, SMA 50 at 9.11%, and SMA 200 at 28.44%. The RSI 14 value is 58.61, suggesting its current momentum. These technical analysis signals help assess CLB's price trends and potential future movements.
Core Laboratories N.V. (CLB) stock performance overview as of December 23, 2025: The 52-week high is $20.82 (currently -20.32% below), and the 52-week low is $9.72 (currently 70.68% above). Over the past year, CLB's performance is -12.5%, compared to the S&P 500's 12.87% change.
According to market data, Core Laboratories N.V. (CLB) stock's recent performance metrics show that over the last month, CLB is 11.19%, with a Year-to-Date (YTD) performance of -4.16%. Over the past year, the stock has seen a -12.5% change. These figures summarize CLB's price movements across various periods, reflecting its historical returns.
According to current financial data, CLB stock's P/E (TTM) ratio is 24.44, which compares to the S&P 500's P/E of 32.59. The sector median P/E is 8.37. Key valuation ratios for CLB, including P/S (1.50), P/B (2.83), and P/FCF (17.16), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep